RECOMBINANT PROTEINS

The invention relates to recombinant proteins useful in the treatment of diseases or disorders associated with MBL-2 deficiency. The invention also relates to nucleic acids encoding such recombinant proteins, expression vector comprising said nucleic acids, as well as and exosomes comprising the rec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	FERNANDES, Francis V A
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to recombinant proteins useful in the treatment of diseases or disorders associated with MBL-2 deficiency. The invention also relates to nucleic acids encoding such recombinant proteins, expression vector comprising said nucleic acids, as well as and exosomes comprising the recombinant proteins, nucleic acids, and/or expression vectors. The invention also relates to cells comprising said recombinant proteins, nucleic acids, expression vectors, and/or exosomes. Disclosed herein are also methods of treating a diseases or disorders associated with MBL-2 deficiency. L'invention concerne des protéines recombinantes utiles dans le traitement de maladies ou de troubles associés à une déficience en MBL-2. L'invention concerne également des acides nucléiques codant pour de telles protéines recombinantes, un vecteur d'expression comprenant lesdits acides nucléiques, ainsi que des exosomes comprenant les protéines recombinantes, les acides nucléiques et/ou les vecteurs d'expression. L'invention concerne en outre des cellules comprenant lesdites protéines recombinantes, des acides nucléiques, des vecteurs d'expression et/ou des exosomes. L'invention concerne également des méthodes de traitement de maladies ou de troubles associés à une déficience en MBL-2.